Callan Family Office’s NetEase NTES Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.97M Buy
15,382
+3,645
+31% +$430K 0.04% 395
2026
Q1
$1.31M Buy
11,737
+291
+3% +$36.1K 0.03% 486
2025
Q4
$1.58M Buy
11,446
+4,637
+68% +$658K 0.03% 413
2025
Q3
$1.03M Buy
6,809
+668
+11% +$91.9K 0.03% 369
2025
Q2
$826K Buy
+6,141
New +$706K 0.03% 446

Other funds holding NTES

Callan Family Office's NTES Position: Q2 2026 in Review

Callan Family Office increased its NetEase (NTES) stake by 31% in Q2 2026, buying an estimated $430K and bringing the position to 15,382 shares worth $1.97M. The position accounts for 0.04% of the portfolio, ranked #395.

Callan Family Office first reported a position in NTES in Q2 2025 and has held it in 5 quarters since. 458 funds tracked by Wall St. Rank hold NTES as of Q2 2026.

  • Callan Family Office held 15,382 shares of NetEase worth $1.97M as of Q2 2026.
  • Callan Family Office bought 3,645 NetEase shares in Q2 2026, an estimated $430K.
  • NetEase made up 0.04% of Callan Family Office's portfolio in Q2 2026, its #395 holding.
  • Callan Family Office first reported a position in NetEase in Q2 2025 and has held it in 5 quarters since.
  • 458 funds tracked by Wall St. Rank held NetEase as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.